Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
ipo
3
×
life sciences
national blog main
texas blog main
texas top stories
allergan
biogen
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
crispr
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
m&a
medical devices
nash
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
venture capital
wisconsin blog main
wisconsin top stories
2025
abbvie
acelity
acquisition
What
years
3
×
bio
ipo
roundup
acelity
acquisitions
allogene
announced
antonio
cancer
ceo
collabs
company
consortium
covid
crispr
daniel
deal
diversity
equity
eyes
firms
gilead
gilead’s
help
hot
immunotherapy
initial
introduce
investors
juno
kinetic
known
medicines
million
month
nearly
new
offering
o’day
Language
unset
Current search:
ipo
×
years
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
San Antonio Wound-Care Company Eyes (Another) Initial Public Offering
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More